Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.

Akhil P SanthoshManoj Kumar GoyalManish ModiParampreet S KharbandaChirag K AhujaNaresh TandyalaNandita PrabhatRajveer SinghSahil MehtaKarthik Vinay Mahesh

Published in: Acta neurologica Scandinavica (2020)

CBZ and LEV could be used as alternatives in newly diagnosed patients of NCC at the behest of minor side effects in the CBZ group.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported